Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chong Zuo

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cancer Cell|March 19, 2020
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic CancerSamarth Hegde, Varintra E Krisnawan, Brett H Herzog, et al.
Cancer Discovery|September 27, 2022
Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint BlockadeVarintra E Lander, Jad I Belle, Natalie L Kingston, et al.
Cancer Cell|May 26, 2023
Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunityXiuting Liu, Graham D Hogg, Chong Zuo, et al.
The Journal of Experimental Medicine|March 23, 2023
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapyChong Zuo, John M Baer, Brett L Knolhoff, et al.
Cancer Cell|May 8, 2026
Dendritic cell redundancy enables priming of anti-tumor CD4<sup>+</sup> T cells in pancreatic cancerCourtney T S Kureshi, Michael J Walsh, Rakeeb Kureshi, et al.
Nature Genetics|August 22, 2022
Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancerDaniel Cui Zhou, Reyka G Jayasinghe, Siqi Chen, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cancer Cell|March 19, 2020
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic CancerSamarth Hegde, Varintra E Krisnawan, Brett H Herzog, et al.
Cancer Discovery|September 27, 2022
Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint BlockadeVarintra E Lander, Jad I Belle, Natalie L Kingston, et al.
Cancer Cell|May 26, 2023
Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunityXiuting Liu, Graham D Hogg, Chong Zuo, et al.
The Journal of Experimental Medicine|March 23, 2023
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapyChong Zuo, John M Baer, Brett L Knolhoff, et al.
Cancer Cell|May 8, 2026
Dendritic cell redundancy enables priming of anti-tumor CD4<sup>+</sup> T cells in pancreatic cancerCourtney T S Kureshi, Michael J Walsh, Rakeeb Kureshi, et al.
Nature Genetics|August 22, 2022
Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancerDaniel Cui Zhou, Reyka G Jayasinghe, Siqi Chen, et al.
Pageof 3